LiverRight and Aegle Medical Solutions, LLC have announced a strategic partnership aimed at helping physicians and healthcare organizations expand access to non-invasive liver assessment, specialist interpretation, diagnosis, and ongoing liver care for patients across the United States. The collaboration brings together Aegle Medical's advanced liver assessment technology and support services with LiverRight's national virtual liver clinic, creating a more connected pathway from liver disease identification to longitudinal management.
For physicians, health systems, and independent practices, the partnership is designed to make it easier to establish or expand comprehensive liver disease programs without building every component internally. Aegle Medical provides a consultative approach to technology evaluation, implementation, training, and ongoing support, while LiverRight offers same-day interpretation services for liver elastography studies and same-week virtual access to its hepatology clinicians. LiverRight's Liververse™ referral system coordinates bloodwork, patient-reported outcomes, available imaging, diagnosis, and longitudinal disease management.
The partnership addresses a critical gap in liver care. According to Brandon Tudor, CEO of LiverRight, "Aegle Medical Solutions is helping hospital systems and independent practices nationwide address the significant number of adults living with undiagnosed liver disease in the United States. By working together, we help practices bring advanced liver assessment into the outpatient setting, provide timely specialist interpretation, and move patients into the appropriate diagnostic and care workflow with greater efficiency."
Michael McTighe, President & CEO of Aegle Medical Solutions, emphasized the strategic importance: "This strategic partnership with LiverRight represents an important step forward in our shared vision of expanding access to liver disease detection and care within the communities we serve. By connecting those capabilities with LiverRight's nationwide virtual liver-care network and same-day interpretation services, we can provide our customers with more than technology we can help them establish a more complete pathway from assessment to diagnosis and ongoing patient management." McTighe added that the model can be particularly valuable for communities where access to hepatology specialists may be limited.
Central to the partnership is the Mindray Hepatus-Series Transient Elastography Diagnostic Ultrasound Systems, which Aegle Medical distributes exclusively in the United States. The Hepatus platform introduces Visualized Transient Elastography (ViTE), a next-generation breakthrough that integrates real-time B-mode ultrasound visualization directly into the elastography examination. Unlike conventional transient elastography platforms that rely primarily on measurement data, ViTE enables operators to see liver anatomy, identify the optimal measurement location, and visually guide each acquisition while obtaining quantitative liver stiffness and attenuation measurements. This evolution combines the efficiency of transient elastography with the clinical confidence of real-time ultrasound visualization in a single examination.
The Hepatus platform provides liver stiffness measurement (LSM) for fibrosis assessment and Liver UltraSound Attenuation (LiSA) for quantitative assessment of hepatic steatosis. The Hepatus 6 further expands capabilities by combining these with diagnostic ultrasound imaging, allowing clinicians to utilize the system for abdominal imaging, Doppler, spleen stiffness assessment, and intestinal ultrasound depending on configuration. McTighe noted, "By bringing advanced elastography, real-time ultrasound visualization, and expanded diagnostic capabilities together on a single platform, Hepatus provides healthcare organizations with an opportunity to modernize liver assessment while improving workflow efficiency and expanding the clinical utility of their investment."
LiverRight has its own hepatologists and hepatology advanced practice providers licensed across all 50 U.S. states, supporting adult patients with conditions including MASLD/MASH, alcohol-associated liver disease, hepatitis B and C, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, and liver cancer diagnosis. The Aegle Medical–LiverRight strategic relationship gives health systems, GI and hepatology practices, and independent providers a scalable approach to expanding liver services under the provider's brand.
For patients, the combined model is designed to bring advanced liver assessment closer to the communities where they already receive care while improving access to liver specialists. The goal is to create a more efficient pathway from identifying at-risk patients to non-invasive assessment, specialist review, diagnosis, and appropriate ongoing care. More information about Aegle Medical Solutions is available at https://www.aeglemedicalsolutions.com and about LiverRight at https://www.liverright.com.
